We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Updated: 12/31/1969
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
Updated: 12/31/1969
MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
Updated: 12/31/1969
MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility Trial Testing the Bionic Pancreas With ZP4207
Updated: 12/31/1969
The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207
Status: Enrolling
Updated: 12/31/1969
Feasibility Trial Testing the Bionic Pancreas With ZP4207
Updated: 12/31/1969
The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Women's Lifestyle Balance Study
Updated: 12/31/1969
Women's Lifestyle and Sleep Intervention for Prediabetes and Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Women's Lifestyle Balance Study
Updated: 12/31/1969
Women's Lifestyle and Sleep Intervention for Prediabetes and Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Monitoring Study
Updated: 12/31/1969
The Monitoring Study: Evaluating the Effect of Remote Monitoring For Hypoglycemia on Bionic Pancreas Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
The Monitoring Study
Updated: 12/31/1969
The Monitoring Study: Evaluating the Effect of Remote Monitoring For Hypoglycemia on Bionic Pancreas Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
Updated: 12/31/1969
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
Status: Enrolling
Updated: 12/31/1969
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
Updated: 12/31/1969
The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
Updated: 12/31/1969
Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
Status: Enrolling
Updated: 12/31/1969
Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
Updated: 12/31/1969
Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments
Updated: 12/31/1969
Enhancing Evidence-based Diabetes Control Among Local Health Departments
Status: Enrolling
Updated: 12/31/1969
Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments
Updated: 12/31/1969
Enhancing Evidence-based Diabetes Control Among Local Health Departments
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Updated: 12/31/1969
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials